ALS longitudinal studies with frequent data collection at home: study design and baseline data

Seward B. RutkoveDepartment of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA, Correspondence[email protected]
View further author information

Kristin QiDepartment of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA, View further author information

Kerisa SheltonDepartment of Neurology, Barrow Neurological Institute, Phoenix, AZ, USA, View further author information

Julie LissDepartment of Speech and Hearing Science, Arizona State University, Phoenix, AZ, USAView further author information

Visar BerishaUniversity of Arizona College of Medicine, Phoenix, AZ, USA, View further author information

Jeremy M. ShefnerDepartment of Neurology, Barrow Neurological Institute, Phoenix, AZ, USA, View further author information

References

Petrov D, Mansfield C, Moussy A, Hermine O. ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment? Vol. 9, Frontiers in Aging Neuroscience. 2017.
Google Scholar
Abe K, Aoki M, Tsuji S, Itoyama Y, Sobue G, Togo M, et al. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol [Internet]. 2017;[cited 2017 Jun 18]16:505–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28522181
PubMed Web of Science ®Google Scholar
Atassi N, Yerramilli-Rao P, Szymonifka J, Yu H, Kearney M, Grasso D, et al. Analysis of start-up, retention, and adherence in ALS clinical trials. Neurology. 2013;81:1350–5.
PubMed Web of Science ®Google Scholar
Dodge HH, Zhu J, Mattek NC, Austin D, Kornfeld J, Kaye JA. Use of high-frequency in-home monitoring data may reduce sample sizes needed in clinical trials. PLoS One. 2015;10:e0138095.
PubMed Web of Science ®Google Scholar
Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13–21.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

ALS longitudinal studies with frequent data collection at home: study design and baseline data

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

ALS longitudinal studies with frequent data collection at home: study design and baseline data

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date